Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Clinical Reviews in Allergy & Immunology

Issue 2/2022

Autoantibodies

Content (12 Articles)

Vasculitis

Serum ANCA as Disease Biomarkers: Clinical Implications Beyond Vasculitis

Marco Folci, Giacomo Ramponi, Virginia Solitano, Enrico Brunetta

Open Access Autoimmune Hepatitis

Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice

Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani

Open Access Rheumatoid Arthritis

Autoantibodies in Rheumatoid Arthritis: Historical Background and Novel Findings

Maria V. Sokolova, Georg Schett, Ulrike Steffen

Open Access Systemic Lupus Erythematosus

The Therapeutic Strategies for SLE by Targeting Anti-dsDNA Antibodies

Yaqi Wang, Shengxiang Xiao, Yumin Xia, Huixia Wang

Systemic Lupus Erythematosus

Antimitochondrial Antibodies: from Bench to Bedside

Francesca Colapietro, Ana Lleo, Elena Generali

Systemic Lupus Erythematosus

Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis

Edward K. L. Chan

Open Access Systemic Lupus Erythematosus

Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus (NPSLE): Can They Be Used as Biomarkers for the Differential Diagnosis of This Disease?

Elias Manca

Systemic Lupus Erythematosus

Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others

Minoru Satoh, Angela Ceribelli, Tomoko Hasegawa, Shin Tanaka

Open Access Polymyositis

An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations

Micaela Fredi, Ilaria Cavazzana, Angela Ceribelli, Lorenzo Cavagna, Simone Barsotti, Elena Bartoloni, Maurizio Benucci, Ludovico De Stefano, Andrea Doria, Giacomo Emmi, Martina Fabris, Marco Fornaro, Federica Furini, Maria Grazia Giudizi, Marcello Govoni, Anna Ghirardello, Luca Iaccarino, Fiorenzo Iannone, Maria Infantino, Natasa Isailovic, Maria Grazia Lazzaroni, Mariangela Manfredi, Alessandro Mathieu, Emiliano Marasco, Paola Migliorini, Carlomaurizio Montecucco, Boaz Palterer, Paola Parronchi, Matteo Piga, Federico Pratesi, Valeria Riccieri, Carlo Selmi, Marilina Tampoia, Alessandra Tripoli, Giovanni Zanframundo, Antonella Radice, Roberto Gerli, Franco Franceschini

Systemic Lupus Erythematosus

The Role of Autoantibody Testing in Modern Personalized Medicine

Cristiane Kayser, Lívia Almeida Dutra, Edgard Torres dos Reis-Neto, Charlles Heldan de Moura Castro, Marvin J. Fritzler, Luis Eduardo C. Andrade

Open Access Dermatomyositis

Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis

Milena Marzęcka, Anna Niemczyk, Lidia Rudnicka

Open Access Antiphospholipid Syndrome

Does Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) Predict the Obstetric Outcome in Antiphospholipid Antibody Carriers? A Single-Center Study

Sara Del Barrio-Longarela, Víctor M. Martínez-Taboada, Pedro Blanco-Olavarri, Ana Merino, Leyre Riancho-Zarrabeitia, Alejandra Comins-Boo, Marcos López-Hoyos, José L. Hernández

Aug 22
Issue: 1/2022
The Primary Immunodeficiencies
Dec 22
Issue: 3/2022
Cutting Edge Issues in Immunologic Disease

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits